Correlates of Uptake of Antiretroviral Therapy in HIV-Positive Orphans and Vulnerable Children Aged 0-14 Years in Tanzania.
0–14 years
AIDS
HIV
Tanzania
antiretroviral therapy
orphans
uptake
vulnerable children
Journal
HIV/AIDS (Auckland, N.Z.)
ISSN: 1179-1373
Titre abrégé: HIV AIDS (Auckl)
Pays: New Zealand
ID NLM: 101515943
Informations de publication
Date de publication:
2020
2020
Historique:
received:
20
04
2020
accepted:
25
06
2020
entrez:
9
8
2020
pubmed:
9
8
2020
medline:
9
8
2020
Statut:
epublish
Résumé
In 2018, only 65% of Tanzanian children aged 0-14 years living with human immunodeficiency virus (HIV) were on treatment, suggesting that challenges exist. This study explores factors associated with uptake of antiretroviral therapy (ART) among HIV-positive orphans and vulnerable children (OVC). Data are from the USAID Kizazi Kipya project that aims to increase the uptake of HIV/AIDS and other health and social services by OVC and their caregivers. HIV-positive OVC aged 0-14 years who were enrolled in the project from January 2017 to September 2018 were analyzed. ART status (off ART or on ART) was the outcome variable. Multivariate analysis was performed using multilevel logistic regression. Of the 10,047 HIV-positive OVC aged 0-14 years analyzed, 93.5% were currently on ART at enrollment. In the multivariate analysis, OVC with male caregivers were 4-times more likely than those with female caregivers to be on ART (OR=4.03, 95% CI=1.49-10.90). OVC with HIV-positive caregivers were 12-times more likely than those with HIV-negative caregivers to be on ART (OR=12.0, 95% CI=3.81-37.70). OVC with caregivers who did not disclose their HIV status were 74% less likely to be on ART than OVC of HIV-negative caregivers (OR=0.26, 95% CI=0.08-0.90). OVC living in urban areas were more than 5-times as likely as their rural counterparts to be on ART (OR=5.55, 95% CI=2.21-14.0). The majority of the OVCLHIV in the current study were currently on ART (93.5%) at enrollment. However, uptake of ART by the OVC was dependent on factors external to themselves. Advancing ART uptake may require targeting OVC of female caregivers, OVC of HIV-negative caregivers, as well as OVC of caregivers of undisclosed HIV statu, and rural areas.
Sections du résumé
BACKGROUND
BACKGROUND
In 2018, only 65% of Tanzanian children aged 0-14 years living with human immunodeficiency virus (HIV) were on treatment, suggesting that challenges exist. This study explores factors associated with uptake of antiretroviral therapy (ART) among HIV-positive orphans and vulnerable children (OVC).
METHODS
METHODS
Data are from the USAID Kizazi Kipya project that aims to increase the uptake of HIV/AIDS and other health and social services by OVC and their caregivers. HIV-positive OVC aged 0-14 years who were enrolled in the project from January 2017 to September 2018 were analyzed. ART status (off ART or on ART) was the outcome variable. Multivariate analysis was performed using multilevel logistic regression.
RESULTS
RESULTS
Of the 10,047 HIV-positive OVC aged 0-14 years analyzed, 93.5% were currently on ART at enrollment. In the multivariate analysis, OVC with male caregivers were 4-times more likely than those with female caregivers to be on ART (OR=4.03, 95% CI=1.49-10.90). OVC with HIV-positive caregivers were 12-times more likely than those with HIV-negative caregivers to be on ART (OR=12.0, 95% CI=3.81-37.70). OVC with caregivers who did not disclose their HIV status were 74% less likely to be on ART than OVC of HIV-negative caregivers (OR=0.26, 95% CI=0.08-0.90). OVC living in urban areas were more than 5-times as likely as their rural counterparts to be on ART (OR=5.55, 95% CI=2.21-14.0).
CONCLUSION
CONCLUSIONS
The majority of the OVCLHIV in the current study were currently on ART (93.5%) at enrollment. However, uptake of ART by the OVC was dependent on factors external to themselves. Advancing ART uptake may require targeting OVC of female caregivers, OVC of HIV-negative caregivers, as well as OVC of caregivers of undisclosed HIV statu, and rural areas.
Identifiants
pubmed: 32765115
doi: 10.2147/HIV.S259074
pii: 259074
pmc: PMC7367717
doi:
Types de publication
Journal Article
Langues
eng
Pagination
233-241Informations de copyright
© 2020 Exavery et al.
Déclaration de conflit d'intérêts
The authors have no competing interests regarding this publication.
Références
PLoS Med. 2018 May 4;15(5):e1002565
pubmed: 29727458
Afr J AIDS Res. 2018 Jul;17(2):193-202
pubmed: 30003844
PLoS One. 2019 Nov 19;14(11):e0219032
pubmed: 31743336
BMC Pregnancy Childbirth. 2015 Aug 15;15:173
pubmed: 26276165
Curr Opin HIV AIDS. 2018 May;13(3):212-219
pubmed: 29570471
Lancet HIV. 2019 Dec;6(12):e831-e859
pubmed: 31439534
J Public Health Policy. 2012;33 Suppl 1:S35-44
pubmed: 23254848
Health Policy Plan. 2006 Nov;21(6):459-68
pubmed: 17030551
Lancet. 2004 Oct 2-8;364(9441):1236-43
pubmed: 15464184
Clin Infect Dis. 2008 Feb 15;46(4):507-15
pubmed: 18199042
J Int AIDS Soc. 2013 Jul 19;16:18588
pubmed: 23870277
Soc Sci Med. 2018 Sep;213:72-84
pubmed: 30059900
N Engl J Med. 2008 Nov 20;359(21):2233-44
pubmed: 19020325
N Engl J Med. 2016 Sep 1;375(9):830-9
pubmed: 27424812
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
AIDS Care. 2010 Sep;22(9):1101-7
pubmed: 20824563
BMC Infect Dis. 2015 Jan 31;15:28
pubmed: 25637106
Clin Infect Dis. 2006 Jul 15;43(2):243-52
pubmed: 16779753
BMC Health Serv Res. 2020 Apr 3;20(1):275
pubmed: 32245468
Int Health. 2016 May;8(3):187-96
pubmed: 27178675